HYB0 Stock Overview
A med-tech company, provides high-tech and medical products worldwide. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 3/6 |
Past Performance | 6/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for HYB0 from our risk checks.
HOYA Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥119.00 |
52 Week High | JP¥130.00 |
52 Week Low | JP¥98.00 |
Beta | 0.63 |
11 Month Change | -2.46% |
3 Month Change | -3.25% |
1 Year Change | 19.00% |
33 Year Change | -16.00% |
5 Year Change | n/a |
Change since IPO | -11.25% |
Recent News & Updates
Recent updates
Shareholder Returns
HYB0 | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | -0.8% | -2.5% | -1.3% |
1Y | 19.0% | -8.4% | 7.4% |
Return vs Industry: HYB0 exceeded the German Medical Equipment industry which returned -7.1% over the past year.
Return vs Market: HYB0 exceeded the German Market which returned 7.1% over the past year.
Price Volatility
HYB0 volatility | |
---|---|
HYB0 Average Weekly Movement | 4.5% |
Medical Equipment Industry Average Movement | 5.2% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.8% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: HYB0 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: HYB0's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1941 | 35,702 | Eiichiro Ikeda | www.hoya.com |
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
HOYA Corporation Fundamentals Summary
HYB0 fundamental statistics | |
---|---|
Market cap | €41.83b |
Earnings (TTM) | €1.21b |
Revenue (TTM) | €5.02b |
34.6x
P/E Ratio8.3x
P/S RatioIs HYB0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HYB0 income statement (TTM) | |
---|---|
Revenue | JP¥812.74b |
Cost of Revenue | JP¥479.57b |
Gross Profit | JP¥333.17b |
Other Expenses | JP¥137.33b |
Earnings | JP¥195.84b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 03, 2025
Earnings per share (EPS) | 562.87 |
Gross Margin | 40.99% |
Net Profit Margin | 24.10% |
Debt/Equity Ratio | 3.3% |
How did HYB0 perform over the long term?
See historical performance and comparison